Literature DB >> 19562731

Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts.

Miller Tran1, Bin Zhou, Pär L Pettersson, Maria J Gonzalez, Stephen P Mayfield.   

Abstract

Monoclonal antibodies can be effective therapeutics against a variety of human diseases, but currently marketed antibody-based drugs are very expensive compared to other therapeutic options. Here, we show that the eukaryotic green algae Chlamydomonas reinhardtii is capable of synthesizing and assembling a full-length IgG1 human monoclonal antibody (mAb) in transgenic chloroplasts. This antibody, 83K7C, is derived from a human IgG1 directed against anthrax protective antigen 83 (PA83), and has been shown to block the effects of anthrax toxin in animal models. Here we show that 83K7C heavy and light chain proteins expressed in the chloroplast accumulate as soluble proteins that assemble into complexes containing two heavy and two light chain proteins. The algal-expressed 83K7C binds PA83 in vitro with similar affinity to the mammalian-expressed 83K7C antibody. In addition, a second human IgG1 and a mouse IgG1 were also expressed and shown to properly assemble in algal chloroplast. These results show that chloroplasts have the ability to fold and assemble full-length human mAbs, and suggest the potential of algae as a platform for the cost effective production of complex human therapeutic proteins. Copyright 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562731     DOI: 10.1002/bit.22446

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  43 in total

1.  The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics.

Authors:  Beth A Rasala; Stephen P Mayfield
Journal:  Bioeng Bugs       Date:  2011 Jan-Feb

Review 2.  Lepidopteran cells, an alternative for the production of recombinant antibodies?

Authors:  Martine Cérutti; Josée Golay
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 3.  The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life.

Authors:  Joris Beld; Eva C Sonnenschein; Christopher R Vickery; Joseph P Noel; Michael D Burkart
Journal:  Nat Prod Rep       Date:  2014-01       Impact factor: 13.423

Review 4.  Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.

Authors:  Beth A Rasala; Stephen P Mayfield
Journal:  Photosynth Res       Date:  2014-03-22       Impact factor: 3.573

5.  Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects.

Authors:  Yangmin Gong; Hanhua Hu; Yuan Gao; Xudong Xu; Hong Gao
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-01       Impact factor: 3.346

Review 6.  Manipulation of the microalgal chloroplast by genetic engineering for biotechnological utilization as a green biofactory.

Authors:  Yong Min Kwon; Kyung Woo Kim; Tae-Young Choi; Sun Young Kim; Jaoon Young Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2018-11-26       Impact factor: 3.312

Review 7.  The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.

Authors:  Fariba Akbari; Morteza Eskandani; Ahmad Yari Khosroushahi
Journal:  World J Microbiol Biotechnol       Date:  2014-08-13       Impact factor: 3.312

8.  Production of unique immunotoxin cancer therapeutics in algal chloroplasts.

Authors:  Miller Tran; Christina Van; Daniel J Barrera; Pär L Pettersson; Carlos D Peinado; Jack Bui; Stephen P Mayfield
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

9.  Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii.

Authors:  Beth A Rasala; Machiko Muto; Philip A Lee; Michal Jager; Rosa M F Cardoso; Craig A Behnke; Peter Kirk; Craig A Hokanson; Roberto Crea; Michael Mendez; Stephen P Mayfield
Journal:  Plant Biotechnol J       Date:  2010-03-07       Impact factor: 9.803

Review 10.  Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives.

Authors:  Sergio Rosales-Mendoza; Luz María Teresita Paz-Maldonado; Ruth Elena Soria-Guerra
Journal:  Plant Cell Rep       Date:  2011-11-12       Impact factor: 4.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.